Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Nuvectis Pharma Inc (NVCT)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 5
  • 1 comments

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Market reaction Comment Full text

GALAPAGOS NV (LKFT)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 3
  • 1 comments

Lakefront ontvangt transparantieverklaring van Madison Avenue Partners

Market reaction Comment Full text

MAGNACHIP SEMICONDUCTOR CORP (MX)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 5
  • 1 comments

Magnachip Appoints Chae Lee as Chief Executive Officer

Market reaction Comment Full text

AGNC INVESTMENT CORP. (AGNC)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 3
  • 1 comments

AGNC Investment Corp. Announces Date for Second Quarter Earnings Release and Stockholder Call

Market reaction Comment Full text

CONCENTRIX CORP (CNXC)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 3
  • 1 comments

Concentrix Reports Second Quarter 2026 Results

Market reaction Comment Full text

BANK OZK (OZK)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 4
  • 1 comments

Bank OZK Announces $200 Million Stock Repurchase Program

Market reaction Comment Full text

MONOLITHIC POWER SYSTEMS INC (MPWR)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 4
  • 1 comments

Monolithic Power Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Monolithic Power Systems, Inc. - MPWR

Market reaction Comment Full text

NUVECTIS PHARMA, INC. (NVCT)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 5
  • 1 comments

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Market reaction Comment Full text

GALAPAGOS NV (LKFT)

  • Business News
  • June 29, 2026, 20:01 UTC
  • 4
  • 1 comments

Lakefront Receives Transparency Notification from Madison Avenue Partners

Market reaction Comment Full text

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • June 29, 2026, 20:00 UTC
  • 5
  • 1 comments

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA

Market reaction Comment Full text
  • Previous
  • 3758
  • 3759
  • 3760
  • 3761
  • 3762
  • Next

Search

News categories

  • Technical Exchange News(14691)
  • Event(6229)
  • SEC News(393485)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239457)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin